Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
Taro Kishi,1 Yuki Matsuda,1 Shinji Matsunaga,1 Masatsugu Moriwaki,1,2 Yoichiro Otake,2 Kaku Akamatsu,3 Tomo Okochi,4 Shigeki Hirano,4 Toshihiko Funahashi,5 Momoko Okuda,6 Hideaki Tabuse,6 Kiyoshi Fujita,2 Nakao Iwata1 1Department of Psychiatry, Fujita Health University School of Medicine, 2Departmen...
Enregistré dans:
| Auteurs principaux: | Kishi T, Matsuda Y, Matsunaga S, Moriwaki M, Otake Y, Akamatsu K, Okochi T, Hirano S, Funahashi T, Okuda M, Tabuse H, Fujita K, Iwata N |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2017
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/e08792372efe44ce84e76d859348dd3c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
par: Soraia Silva, et autres
Publié: (2021) -
Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study
par: Otsubo T, et autres
Publié: (2018) -
Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety
par: Wang G, et autres
Publié: (2018) -
Mind your state: Insights into antidepressant nonadherence
par: De Wet Wolmarans, et autres
Publié: (2016) -
Dosage-related nature of escitalopram treatment-emergent mania/hypomania: a case series
par: Yamaguchi Y, et autres
Publié: (2018)